iifl-logo

Senores Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
1,449.5
(-0.36%)
Sep 2, 2026|09:01:45 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Senores Pharmaceuticals Ltd Historical Data

02/08/2026calendar-icon
02/09/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

03-Aug-2026

1,326.6

1,364.41,312.11,355.315,82526,84,59,268.593,928

04-Aug-2026

1,369

1,3701,3441,360.57,49414,16,83,67047,029

05-Aug-2026

1,371.5

1,3741,306.11,323.322,41557,47,26,3952,07,281

06-Aug-2026

1,335

1,345.61,3241,328.57,29412,05,93,903.144,139

07-Aug-2026

1,328.5

1,359.91,3101,342.622,06529,01,29,765.583,768

10-Aug-2026

1,347.7

1,4381,325.11,422.233,27378,97,00,026.42,91,570

11-Aug-2026

1,429.3

1,496.31,410.81,475.722,82360,75,77,192.51,81,089

12-Aug-2026

1,475.7

1,5011,4551,492.419,43139,69,83,677.71,29,400

13-Aug-2026

1,494

1,514.81,471.81,491.410,77418,24,14,424.150,307

14-Aug-2026

1,491.4

1,509.91,470.11,477.79,50114,78,79,550.342,808

17-Aug-2026

1,486

1,549.81,471.31,545.723,75555,18,06,724.51,72,526

18-Aug-2026

1,549.7

1,562.91,525.51,537.524,04136,89,12,154.91,02,617

19-Aug-2026

1,544.3

1,577.51,526.91,550.913,31625,30,73,608.849,570

20-Aug-2026

1,568.8

1,5691,484.51,513.39,16722,57,81,895.564,755

21-Aug-2026

1,519.8

1,537.21,495.71,513.39,32114,21,39,317.836,177

24-Aug-2026

1,521

1,5991,492.11,515.730,49367,68,05,727.31,73,224

25-Aug-2026

1,508

1,5081,456.31,480.416,79729,48,52,680.976,409

26-Aug-2026

1,494.2

1,523.21,480.51,494.712,27322,17,44,058.339,362

27-Aug-2026

1,501.4

1,513.71,461.11,474.611,86725,55,78,799.185,453

28-Aug-2026

1,474.6

1,4941,466.21,482.17,00712,50,00,430.434,064

31-Aug-2026

1,484.8

1,500.11,423.11,432.822,97347,01,21,195.21,70,357

01-Sep-2026

1,442.3

1,469.91,424.31,454.718,71370,89,66,887.93,26,863

Senores Pharmaceuticals Ltd: Related NEWS

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

The acquisition will be carried out in two tranches and has received approval from the management committee of the company’s board.

16 Dec 2025|11:27 AM
Read More
Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

5 Mar 2025|11:05 AM
Read More
Senores Stock Dips from High, Remains Above IPO Price

Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.

30 Dec 2024|04:08 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.